Huajin Capital
华金资本
Huajin CapitalFund
华金资本
渲染中…
Mentioned in 8 articles
Coverage
New Forces Keep Coming｜5Y News Monthly
The big news from last month.
五源资本·5Y News | Zai Ling Bio Completes Nearly RMB 600 Million Series C Financing
The funding will go toward global clinical development, pipeline expansion, and technology platform upgrades.
五源资本·Rongbao | Embodied intelligence, chips accelerate commercial rollout and R&D; AI transforms creative industries, finance, and more
Several companies made it onto the annual lists by *China Entrepreneur* and *Fortune*.
高榕创投·CoreVision Biopharma Closes Series A to Accelerate Global Clinical Development of Targeted Radiopharmaceuticals
Advancing a BIC/FIC dual-driven pipeline with a global perspective.
高榕创投·Rongbao | Major Acquisition in Innovative Drugs; Laser Chips, Quantum Computing, and Global Payment Platform Secure New Funding
"Every step forward feels like a bloom."
高榕创投·Onto Innovation Completes Over $50 Million Series A Financing to Accelerate Deep Pipeline Expansion in Nucleic Acid Drugs
Focused on drug development based on antisense oligonucleotide technology.
高榕创投·Haijieya Completes New Funding Round to Build Integrated Platform for Interventional Oncology Treatment
Providing a comprehensive suite of minimally invasive interventional diagnosis and treatment solutions for oncology.
高榕创投·Gaorong Monthly · December | Gaorong Ventures and Its Frontier Tech / Consumer / Healthcare / Enterprise Service Portfolio Companies Win Multiple Annual Awards
Its technological and innovative capabilities have won recognition.
高榕创投·
